Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey Graham

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Cancer Treatment Reviews|October 10, 2017
Adjuvant therapy in renal cell carcinomaFrancesco Massari, Vincenzo Di Nunno, Chiara Ciccarese, et al.
BMC Public Health|May 6, 2024
The contribution and interplay of implicit and explicit processes on physical activity behavior: empirical testing of the physical activity adoption and maintenance (PAAM) modelDarko Jekauc, Ceren Gürdere, Chris Englert, et al.
Clinical Genitourinary Cancer|March 23, 2024
Association of Cabozantinib Dose Reductions for Toxicity With Clinical Effectiveness in Metastatic Renal Cell Carcinoma (mRCC): Results From the Canadian Kidney Cancer Information System (CKCis)Jeffrey Graham, Sunita Ghosh, Rodney H Breau, et al.
JCO Global Oncology|November 22, 2023
Trends of Utilization of Systemic Therapies for Metastatic Renal Cell Carcinoma in the Canadian Health Care SystemLuisa M Cardenas, Sunita Ghosh, Antonio Finelli, et al.
Clinical Genitourinary Cancer|January 14, 2020
Clinical Outcomes of First-line Sunitinib Followed by Immuno-oncology Checkpoint Inhibitors in Patients With Metastatic Renal Cell CarcinomaJ Connor Wells, Jeffrey Graham, Benoit Beuselinck, et al.
Cancer Reports (Hoboken, N.J.)|December 14, 2022
Evaluating the impact of early identification of asymptomatic brain metastases in metastatic renal cell carcinomaAmbica Parmar, Sunita Ghosh, Arjun Sahgal, et al.
BJU International|February 6, 2021
Outcomes of systemic targeted therapy in recurrent renal cell carcinoma treated with adjuvant sunitinibGuillermo de Velasco, Álvaro Ruiz-Granados, Oscar Reig, et al.
Clinical Genitourinary Cancer|May 1, 2026
Bone Metastases and Use of Bone Protective Agents for Metastatic Clear Cell Renal Cell Carcinoma: A Contemporary National Real-World AnalysisBraden Millan, Sunita Ghosh, Naveen S Basappa, et al.
Advances in Radiation Oncology|July 11, 2022
Outcomes of Radiation Therapy Plus Immunotherapy in Metastatic Renal Cell Carcinoma: Results From the Canadian Kidney Cancer Information SystemEric K Nguyen, Aly Khan A Lalani, Sunita Ghosh, et al.
Cardio-Oncology (London, England)|January 8, 2026
Can flaxseed "milk" prevent anthracycline mediated cardiotoxicity in women with breast cancer (CANFLAX-BC)?Vibhuti Arya, Lana Mackic, Sara M Telles Langdon, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Cancer Treatment Reviews|October 10, 2017
Adjuvant therapy in renal cell carcinomaFrancesco Massari, Vincenzo Di Nunno, Chiara Ciccarese, et al.
BMC Public Health|May 6, 2024
The contribution and interplay of implicit and explicit processes on physical activity behavior: empirical testing of the physical activity adoption and maintenance (PAAM) modelDarko Jekauc, Ceren Gürdere, Chris Englert, et al.
Clinical Genitourinary Cancer|March 23, 2024
Association of Cabozantinib Dose Reductions for Toxicity With Clinical Effectiveness in Metastatic Renal Cell Carcinoma (mRCC): Results From the Canadian Kidney Cancer Information System (CKCis)Jeffrey Graham, Sunita Ghosh, Rodney H Breau, et al.
JCO Global Oncology|November 22, 2023
Trends of Utilization of Systemic Therapies for Metastatic Renal Cell Carcinoma in the Canadian Health Care SystemLuisa M Cardenas, Sunita Ghosh, Antonio Finelli, et al.
Clinical Genitourinary Cancer|January 14, 2020
Clinical Outcomes of First-line Sunitinib Followed by Immuno-oncology Checkpoint Inhibitors in Patients With Metastatic Renal Cell CarcinomaJ Connor Wells, Jeffrey Graham, Benoit Beuselinck, et al.
Cancer Reports (Hoboken, N.J.)|December 14, 2022
Evaluating the impact of early identification of asymptomatic brain metastases in metastatic renal cell carcinomaAmbica Parmar, Sunita Ghosh, Arjun Sahgal, et al.
BJU International|February 6, 2021
Outcomes of systemic targeted therapy in recurrent renal cell carcinoma treated with adjuvant sunitinibGuillermo de Velasco, Álvaro Ruiz-Granados, Oscar Reig, et al.
Clinical Genitourinary Cancer|May 1, 2026
Bone Metastases and Use of Bone Protective Agents for Metastatic Clear Cell Renal Cell Carcinoma: A Contemporary National Real-World AnalysisBraden Millan, Sunita Ghosh, Naveen S Basappa, et al.
Advances in Radiation Oncology|July 11, 2022
Outcomes of Radiation Therapy Plus Immunotherapy in Metastatic Renal Cell Carcinoma: Results From the Canadian Kidney Cancer Information SystemEric K Nguyen, Aly Khan A Lalani, Sunita Ghosh, et al.
Cardio-Oncology (London, England)|January 8, 2026
Can flaxseed "milk" prevent anthracycline mediated cardiotoxicity in women with breast cancer (CANFLAX-BC)?Vibhuti Arya, Lana Mackic, Sara M Telles Langdon, et al.
Pageof 6